Article Versions Notes

Kwatra SG, Boozalis E, Huang AH, Nanni C, Khanna R, Williams KA, Semenov YR, Roberts CM, Burns RF, Krischak M, et al. Proteomic and Phosphoproteomic Analysis Reveals that Neurokinin-1 Receptor (NK1R) Blockade with Aprepitant in Human Keratinocytes Activates a Distinct Subdomain of EGFR Signaling: Implications for the Anti-Pruritic Activity of NK1R Antagonists. Medicines. 2019; 6(4):114. https://doi.org/10.3390/medicines6040114

Kwatra, Shawn G., Emily Boozalis, Amy H. Huang, Cory Nanni, Raveena Khanna, Kyle A. Williams, Yevgeniy R. Semenov, Callie M. Roberts, Robert F. Burns, Madison Krischak, and et al. 2019. "Proteomic and Phosphoproteomic Analysis Reveals that Neurokinin-1 Receptor (NK1R) Blockade with Aprepitant in Human Keratinocytes Activates a Distinct Subdomain of EGFR Signaling: Implications for the Anti-Pruritic Activity of NK1R Antagonists" Medicines 6, no. 4: 114. https://doi.org/10.3390/medicines6040114

Kwatra, S. G., Boozalis, E., Huang, A. H., Nanni, C., Khanna, R., Williams, K. A., Semenov, Y. R., Roberts, C. M., Burns, R. F., Krischak, M., & Kwatra, M. M. (2019). Proteomic and Phosphoproteomic Analysis Reveals that Neurokinin-1 Receptor (NK1R) Blockade with Aprepitant in Human Keratinocytes Activates a Distinct Subdomain of EGFR Signaling: Implications for the Anti-Pruritic Activity of NK1R Antagonists. Medicines, 6(4), 114. https://doi.org/10.3390/medicines6040114